Metagenomic Sequencing Market Growth Analysis With Investment Opportunities For 2024-2033

July 23, 2024 08:24 PM AEST | By EIN Presswire
 Metagenomic Sequencing Market Growth Analysis With Investment Opportunities For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, July 23, 2024 /EINPresswire.com/ -- The metagenomic sequencing market has experienced robust growth in recent years, expanding from $1.82 billion in 2023 to $2.13 billion in 2024 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to increasing involvement of the government, the growing number of metagenome sequencing research projects, growing application of metagenomics in genomics and diagnostics research, the availability of research funding, the development of NGS data analysis tools.

Strong Future Growth Anticipated
The metagenomic sequencing market is projected to continue its strong growth, reaching $4.02 billion in 2028 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to decreasing computational costs, growing focus on discovering novel biomolecules of interest, increasing adoption of high-throughput sequencing technologies, demand for personalized medicine and disease diagnosis, surge in prevalence of infectious diseases.

Explore Comprehensive Insights Into The Global Metagenomic Sequencing Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16117&type=smp

Growth Driver Of The Metagenomic Sequencing Market
The surge in the prevalence of infectious diseases is expected to drive the growth of the metagenomic sequencing market. Infectious diseases are disorders caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread, directly or indirectly, from one person to another. The increasing prevalence of conditions that weaken the immune system, such as HIV/AIDS, cancer treatments, and autoimmune disorders, can make individuals more susceptible to infectious diseases. Metagenomic sequencing offers a powerful and versatile approach to studying infectious diseases, providing valuable insights into pathogen diversity, transmission dynamics, antimicrobial resistance, and outbreak surveillance.

Order Your Report Now For Swift Delivery:
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Major Players And Market Trends
Key players in the metagenomic sequencing market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc.
Major companies operating in the metagenomic sequencing market are focusing on innovating sequencing services, to improve sequencing accuracy, throughput, and cost-effectiveness. Sequencing services refer to cutting-edge genomic technologies that enable the sequencing of longer DNA fragments, providing a more comprehensive view of genetic structures compared to traditional short-read methods.

Segments:
1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions
2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics
3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Geographical Insights: North America Leading The Market
North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Metagenomic Sequencing Market Definition
Metagenomic sequencing is a technique used to analyze the genetic material from an entire community of microorganisms found in a specific environment, without the need for culturing individual species. The method involves the extraction of DNA directly from environmental samples, such as soil, water, or the human gut. The extracted DNA is then sequenced using high-throughput sequencing technologies.

Metagenomic Sequencing Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Metagenomic Sequencing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on metagenomic sequencing market size, metagenomic sequencing market drivers and trends, metagenomic sequencing market major players, metagenomic sequencing competitors' revenues, metagenomic sequencing market positioning, and metagenomic sequencing market growth across geographies. The metagenomic sequencing market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Metagenomics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Clinical Oncology Next Generation Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Next Generation Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.